核积聚变化发生在肌缩侧面硬化症中的变化
Ioannis N Mavridis1,2, Efstratios-Stylianos Pyrgelis1,3
1"C.N.S. Alliance" Research Group Athens, Greece.
American journal of neurodegenerative disease
|July 17, 2023
概括
肌缩侧面硬化症 (ALS) 涉及到核缩 (NA) 的变化,包括与神经元损失相关的缩. 这些NA变化可能会导致ALS患者的行为和认知问题.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,影响运动神经元.
- 中核 (NA) 是腹状条纹体的一部分,调节大脑的奖励网络.
研究的目的:
- 审查当前关于肌缩性侧面硬化症 (ALS) 患者中核缩 (NA) 变化的知识.
主要方法:
- 关于ALS中NA变化的最新成像和病理学研究的综述.
- 在NA内对体积,细胞和分子变化的分析.
主要成果:
- 通过成像和病理学研究表明,ALS患者的NA缩的证据.
- 缩似乎与神经元损失和NA中的蛋白质沉积有关.
结论:
- 核 (NA) 在肌缩侧面硬化症 (ALS) 中发生显著变化.
- 在ALS中,NA缩可能与临床表现相关,如冷漠,行为障碍和认知障碍.
相关概念视频
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Parkinson's Disease: Overview
604
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
604
Cross-bridge Cycle
117.7K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.7K
Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K


